VOYXACT 200 mg/mL
sibeprenlimab · INJECTION · Otsuka America Pharmaceutical, Inc.
No Recall History
Plain English
VOYXACT is a injection containing sibeprenlimab at 200 mg/mL, taken subcutaneous. Manufactured by Otsuka America Pharmaceutical, Inc..
Key Facts
- Brand Name
- VOYXACT
- Generic Name
- sibeprenlimab
- NDC Code (Product)
59148-400- Manufacturer
- Otsuka America Pharmaceutical, Inc.
- Strength
- 200 mg/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761434
- Marketing Start
- 11/25/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is VOYXACT used for?
VOYXACT contains sibeprenlimab. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is VOYXACT a controlled substance?
VOYXACT is not classified as a controlled substance by the DEA.
What is the generic name for VOYXACT?
The generic name for VOYXACT is sibeprenlimab. There are no other listed brand versions of sibeprenlimab.
What is the NDC code for VOYXACT 200 mg/mL?
The NDC (National Drug Code) for VOYXACT 200 mg/mL is 59148-400, listed by Otsuka America Pharmaceutical, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)